FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249232426> ?p ?o ?g. }

• W4249232426 endingPage "2179" @default.
• W4249232426 startingPage "2179" @default.
• W4249232426 abstract "Abstract Androgen receptor (AR) antagonists have transformed prostate cancer patient care by targeting a key nodal point in tumor cell signaling. However, despite the impressive clinical activity of first- and second-generation antiandrogens, acquired resistance frequently emerges. Point mutations in the ligand-binding domain of AR, such as phenylalanine to leucine at position 877 (ARF877L), account for 10-20% of resistance. Such mutations are characterized by receptor activation, rather than inhibition, by first- and second-generation antiandrogen therapeutics. JNJ-63576253 is a potent, high affinity competitive binder of wild type and mutant AR, including F877L. JNJ-63576253 blocks AR nuclear translocation, AR binding to DNA, and AR-dependent transcription. JNJ-63576253 inhibits the proliferation of androgen receptor driven prostate cancer cell lines, including those bearing ARF877L. In the Hershberger assay in male Sprague Dawley rats, oral administration of JNJ-63576253 inhibited androgen sensitive organ (ASO) development in a dose-dependent manner. In male SHO mice bearing LNCaP xenografts with either wild-type or ARF877L, daily treatment with 30 mg/kg JNJ-63576253 treatment resulted in statistically significant antitumor activity, whereas second-generation antiandrogen enzalutamide had no antitumor efficacy in the LNCaP ARF877L mutant model. Janssen and Tracon Pharma have entered a strategic licensing collaboration, whereby Tracon possesses exclusive rights for clinical development of JNJ-63576253 (now called TRC253). Tracon has entered TRC253 into Ph1/2A clinical evaluation in metastatic castration-resistant prostate cancer patients. Citation Format: Tammy L. Bush, Georges Habineza Ndikuyeze, Gilles Bignan, Jonathan Branch, Janine Ondrus, Yifan Shi, Leopoldo Luistro, James Hastings, Joseph Erhardt, Ian Hickson, Shefali Patel, Peter Connolly, Zhuming Zhang, James Bischoff, Brent Rupnow, Marco Gottardis, Kathryn Packman. Antitumor activity of JNJ-63576253 (TRC253), a small molecule antagonist of F877L mutant and wild-type androgen receptor [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2179." @default.
• W4249232426 created "2022-05-12" @default.
• W4249232426 creator A5005659795 @default.
• W4249232426 creator A5012789782 @default.
• W4249232426 creator A5024849457 @default.
• W4249232426 creator A5026133059 @default.
• W4249232426 creator A5037197542 @default.
• W4249232426 creator A5038227068 @default.
• W4249232426 creator A5040094376 @default.
• W4249232426 creator A5040639227 @default.
• W4249232426 creator A5044912332 @default.
• W4249232426 creator A5047983659 @default.
• W4249232426 creator A5075523055 @default.
• W4249232426 creator A5077611702 @default.
• W4249232426 creator A5078842144 @default.
• W4249232426 creator A5082297714 @default.
• W4249232426 creator A5082633128 @default.
• W4249232426 creator A5085227264 @default.
• W4249232426 creator A5085921889 @default.
• W4249232426 date "2019-07-01" @default.
• W4249232426 modified "2023-09-27" @default.
• W4249232426 title "Abstract 2179: Antitumor activity of JNJ-63576253 (TRC253), a small molecule antagonist of F877L mutant and wild-type androgen receptor" @default.
• W4249232426 doi "https://doi.org/10.1158/1538-7445.am2019-2179" @default.
• W4249232426 hasPublicationYear "2019" @default.
• W4249232426 type Work @default.
• W4249232426 citedByCount "0" @default.
• W4249232426 crossrefType "journal-article" @default.
• W4249232426 hasAuthorship W4249232426A5005659795 @default.
• W4249232426 hasAuthorship W4249232426A5012789782 @default.
• W4249232426 hasAuthorship W4249232426A5024849457 @default.
• W4249232426 hasAuthorship W4249232426A5026133059 @default.
• W4249232426 hasAuthorship W4249232426A5037197542 @default.
• W4249232426 hasAuthorship W4249232426A5038227068 @default.
• W4249232426 hasAuthorship W4249232426A5040094376 @default.
• W4249232426 hasAuthorship W4249232426A5040639227 @default.
• W4249232426 hasAuthorship W4249232426A5044912332 @default.
• W4249232426 hasAuthorship W4249232426A5047983659 @default.
• W4249232426 hasAuthorship W4249232426A5075523055 @default.
• W4249232426 hasAuthorship W4249232426A5077611702 @default.
• W4249232426 hasAuthorship W4249232426A5078842144 @default.
• W4249232426 hasAuthorship W4249232426A5082297714 @default.
• W4249232426 hasAuthorship W4249232426A5082633128 @default.
• W4249232426 hasAuthorship W4249232426A5085227264 @default.
• W4249232426 hasAuthorship W4249232426A5085921889 @default.
• W4249232426 hasConcept C104317684 @default.
• W4249232426 hasConcept C121608353 @default.
• W4249232426 hasConcept C126322002 @default.
• W4249232426 hasConcept C134018914 @default.
• W4249232426 hasConcept C143065580 @default.
• W4249232426 hasConcept C170493617 @default.
• W4249232426 hasConcept C185592680 @default.
• W4249232426 hasConcept C207583985 @default.
• W4249232426 hasConcept C2776551883 @default.
• W4249232426 hasConcept C2777911890 @default.
• W4249232426 hasConcept C2779322244 @default.
• W4249232426 hasConcept C2779723316 @default.
• W4249232426 hasConcept C2780192828 @default.
• W4249232426 hasConcept C502942594 @default.
• W4249232426 hasConcept C55493867 @default.
• W4249232426 hasConcept C61367390 @default.
• W4249232426 hasConcept C71315377 @default.
• W4249232426 hasConcept C71924100 @default.
• W4249232426 hasConcept C98274493 @default.
• W4249232426 hasConceptScore W4249232426C104317684 @default.
• W4249232426 hasConceptScore W4249232426C121608353 @default.
• W4249232426 hasConceptScore W4249232426C126322002 @default.
• W4249232426 hasConceptScore W4249232426C134018914 @default.
• W4249232426 hasConceptScore W4249232426C143065580 @default.
• W4249232426 hasConceptScore W4249232426C170493617 @default.
• W4249232426 hasConceptScore W4249232426C185592680 @default.
• W4249232426 hasConceptScore W4249232426C207583985 @default.
• W4249232426 hasConceptScore W4249232426C2776551883 @default.
• W4249232426 hasConceptScore W4249232426C2777911890 @default.
• W4249232426 hasConceptScore W4249232426C2779322244 @default.
• W4249232426 hasConceptScore W4249232426C2779723316 @default.
• W4249232426 hasConceptScore W4249232426C2780192828 @default.
• W4249232426 hasConceptScore W4249232426C502942594 @default.
• W4249232426 hasConceptScore W4249232426C55493867 @default.
• W4249232426 hasConceptScore W4249232426C61367390 @default.
• W4249232426 hasConceptScore W4249232426C71315377 @default.
• W4249232426 hasConceptScore W4249232426C71924100 @default.
• W4249232426 hasConceptScore W4249232426C98274493 @default.
• W4249232426 hasIssue "13_Supplement" @default.
• W4249232426 hasLocation W42492324261 @default.
• W4249232426 hasOpenAccess W4249232426 @default.
• W4249232426 hasPrimaryLocation W42492324261 @default.
• W4249232426 hasRelatedWork W1528618484 @default.
• W4249232426 hasRelatedWork W2104364640 @default.
• W4249232426 hasRelatedWork W2555204225 @default.
• W4249232426 hasRelatedWork W2567523803 @default.
• W4249232426 hasRelatedWork W2740124347 @default.
• W4249232426 hasRelatedWork W2772229485 @default.
• W4249232426 hasRelatedWork W2948523439 @default.
• W4249232426 hasRelatedWork W2966112499 @default.
• W4249232426 hasRelatedWork W4362477333 @default.
• W4249232426 hasRelatedWork W4362478213 @default.
• W4249232426 hasVolume "79" @default.
• W4249232426 isParatext "false" @default.

• next